Thursday - March 05, 2026

Category Archives: Business

Antibody-Drug Conjugates Oncology Intelligence Breakthrough: 200+ Companies, 220+ Therapeutics, 6 Key Strategic Insights Reshaping the Global Competitive Landscape, analyses DelveInsight

Antibody-Drug Conjugates in Oncology Pipeline Leading companies working in the Antibody-Drug Conjugates in Oncology market are Jiangsu Hengrui Medicine Co., Bio-Thera Solutions, MediLink Therapeutics, Byondis, AbbVie, Oxford BioTherapeutics, Iksuda Therapeutics, Novelty Nobility, LegoChem Biosciences, DualityBio, Lepu Biopharma, Ambrx, CSPC ZhongQi … Continue reading →

Personal Care Contract Manufacturing Market to Reach USD 42.72 Billion by 2032 Amid Rising Global Outsourcing Demand, analyses DelveInsight

Personal Care Contract Manufacturing Market Leading Personal Care Contract Manufacturing companies operating in this market include Albea Group, McBride, Colep Consumer Products, PLZ Corp., Voyant Beauty, Formula Corp., INTERCOS S.P.A., H.S.A. Hair Styling Applications S.p.A., Clarion Cosmetics, COMECER S.p.A., Novo … Continue reading →

Dry Eye Disease Market Valued at ~USD 3.76 Billion in 2023, Projected to Expand Significantly by 2034, Reports DelveInsight

Dry Eye Disease Market Leading companies advancing innovative therapies in Dry Eye Disease (DED) include Palatin Technologies, Aldeyra Therapeutics, ReGenTree / RegeneRx Biopharmaceuticals, Mimetogen, Alcon / Aerie Pharmaceuticals, BRIM Biotechnology, Seikagaku Corporation, Mitotech, Senju Pharmaceutical, Sylentis / PharmaMar, Stuart Therapeutics, … Continue reading →

Desmoid Tumors Market to Surpass USD 89 Million Baseline with 68% U.S. Share and 28,400 CTNNB1 Cases – Forecast to Accelerate Through 2034, Reports DelveInsight

Desmoid Tumors Market Leading Desmoid Tumors companies include SpringWorks Therapeutics, Immunome / Ayala Pharmaceuticals, Iterion Therapeutics, Eisai, PRISM BioLab, MedPacto, Inc., Pfizer, Novartis, Aadi Bioscience, Inc., INSYS Therapeutics Inc, Recursion Pharmaceuticals Inc, among others actively engaged in advancing therapeutic innovation. … Continue reading →

Radiofrequency Ablation Devices Market Set to Surpass USD 9.12 Billion by 2032, Driven by Surging Cancer and Cardiovascular Disease Burden Worldwide, analyses DelveInsight

Radiofrequency Ablation Devices Market DelveInsight’s New Report Reveals 11.16% CAGR Growth, Spotlighting AI Integration, Key Players, and Regional Dynamics Reshaping Global Radiofrequency Ablation DelveInsight Business Research LLP, a premier life sciences market research and consulting firm, today announced the release … Continue reading →

Aducanumab Market Forecast 2034: Strategic Insights, Sales Projections, Competitive Landscape, and Growth Opportunities Across the 7MM, analyses DelveInsight

Aducanumab Market Aducanumab received accelerated approval for early-stage Alzheimer’s disease, including mild cognitive impairment (MCI) due to AD and mild AD dementia. The approval was based on its demonstrated ability to reduce amyloid plaques, a surrogate endpoint under the amyloid … Continue reading →

Aficamten Sales Forecast Through 2034 Signals Strong Commercial Momentum in Obstructive Hypertrophic Cardiomyopathy | DelveInsight

Aficamten Sales Market Aficamten’s growth is primarily driven by strong unmet need in symptomatic obstructive hypertrophic cardiomyopathy (oHCM), compelling Phase III efficacy data, and its next-generation cardiac myosin inhibition profile. Predictable pharmacokinetics, rapid reversibility, and simplified dosing position it for … Continue reading →

FYLNETRA Sales Forecast 2034: Strong U.S. Uptake, Expanding Oncology Footprint, and Competitive Pricing Dynamics to Shape Long-Term Growth | DelveInsight

FYLNETRA Sales FYLNETRA’s growth is driven by accelerating biosimilar adoption in oncology supportive care, payer-led switching from branded pegfilgrastim, and strong formulary inclusion across U.S. hospitals and infusion centers. Coherus’ focused commercial execution, contracting strategies, and engagement with oncology networks … Continue reading →

Eosinophilic Esophagitis Market Expected to Exceed USD 1.8 Billion by 2034 with Nearly 65% of Diagnosed Patients Located in the US, analyses DelveInsight

Eosinophilic Esophagitis Market Eosinophilic Esophagitis Companies are Ellodi Pharmaceuticals, AstraZeneca, Regeneron Pharmaceuticals, Sanofi, Bristol-Myers Squibb, Allakos, EsoCap AG, Pfizer, Ception Therapeutics, Celgene, Dr. Falk Pharma GmbH, Revolo Biotherapeutics, Shire, Novartis, EMS, Celgene, Oxagen Ltd, Meritage Pharma, Inc, Forest Laboratories, and … Continue reading →

Embolic Protection Devices Market to Reach USD 1,161.31 Million by 2032, Growing at a CAGR of 7.58% | DelveInsight

Embolic Protection Devices Market Some of the key market players operating in the embolic protection devices market include Boston Scientific Corporation, Abbott, Medtronic, Cordis, Contego Medical, Inc., Integer Holdings Corporation, InspireMD Inc., Emboline, Inc., Keystone Heart Ltd., Lepu Medical Technology(Beijing) … Continue reading →